J Korean Diabetes.
2021 Jun;22(2):85-90. 10.4093/jkd.2021.22.2.85.
Recent Perspective of Metformin
- Affiliations
-
- 1Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea
- KMID: 2526185
- DOI: http://doi.org/10.4093/jkd.2021.22.2.85
Abstract
- Metformin has been used clinically more than 60 years in type 2 diabetes as the first-line drug for treatment. Metformin has been prescribed in more than 80% of Korean patients with diabetes. Despite long-term use and wide prescription of metformin in patients with type 2 diabetes, many questions remain. Recent advances have revealed a new mechanism of action and new benefits of metformin. In this article, we review recent advances regarding metformin treatment.
